DEXMEDETOMIDINE HYDROCHLORIDE (dexmedetomidine) by Accord Biopharma is 12. First approved in 2016.
Drug data last refreshed 19h ago
12.1 Mechanism of Action Dexmedetomidine is a relatively selective centrally acting alpha 2 -adrenergic agonist with sedative properties. Alpha 2 selectivity is observed in animals following slow intravenous infusion of low and medium doses (10 mcg/kg to 300 mcg/kg). Both alpha 1 and alpha 2…
Worked on DEXMEDETOMIDINE HYDROCHLORIDE at Accord Biopharma? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Effect of Sublingual Formulation of Dexmedetomidine Hydrochloride (HCl) (BXCL501) - Outpatient Study
Effect of Perioperative Dexmedetomidine on Chronic Post-Surgical Pain
Liposomal Bupivacaine Vs Bupivacaine with Dexmedetomidine in Erector Spinae Plane Blocks for Mastectomies
Postoperative Dexmedetomidine in Prevention of Postoperative Delirium
Different Administration Routes of Dexmedetomidine on Postoperative Delirium